VEViktor I. Egorov

Viktor I. Egorov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Viktor I. Egorov has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • OROPHARYNGEAL HEMANGIOMA: A CASE REPORT

    by E.I. Putkaradze, D.M. Mustafaev, V.I. Egorov, G.R. Setdikova, M.U. Magomedov

    Background. Hemangioma is a congenital vascular anomaly characterized by hyperplasia of endothelial cells. It is rarely found in adults, particularly in oropharynx. Adult hemangiomas do not regress spontaneously but progress relatively slowly and they are often asymptomatic. Materials and methods. This paper reports a rare clinical case of lobular hemangioma of the palatopharyngeal arch in a 51-year-old woman. Diagnostic evaluation of the neoplasm included an endoscopic examination and radiological imaging. treatment consisted of complete surgical excision using a cold plasma device followed by histopathological verification. Preoperative biopsy was avoided due to the high risk of massive bleeding. Conclusions. For localised pedunculated oropharyngeal hemangiomas, cold-plasma surgery is an effective surgical treatment modality, providing a controlled effect on tissues, the possibility of simultaneous hemostasis and a favorable course of the postoperative period. The rarity of hemangioma localization on the posterior palatine arch in an adult patient determines the scientific and practical value of the presented clinical observation.

  • First experience of using tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps in the Moscow region

    by V.I. Egorov, E.YU. Savushkina

    Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the nasal mucosa and paranasal sinuses associated with severe nasal congestion, olfactory impairment, decreased quality of life, the need for repeated surgical interventions, and the use of systemic glucocorticosteroids. Real-world data on the use of tezepelumab in patients with severe relapsing CRSwNP remain limited. Objective. To describe the initial experience of tezepelumab application in real-world setting in patients with recurrent rhinosinusitis with nasal polyps and to evaluate early improvement of symptoms, quality of life, and tolerability of therapy based on available clinical data. Material and methods. We describe clinical observations of 8 patients with recurrent CRSwNP who received tezepelumab 210 mg subcutaneously every 4 weeks for 2 months. Patients were treated in a multidisciplinary day hospital. The total severity of symptoms was assessed using the visual analogue scale (VAS), quality of life — using the SNOT-22 questionnaire, the initial endoscopic picture — using the Lund-Kennedy score. In addition, peripheral blood eosinophils, treatment history, comorbidity and tolerability of therapy were evaluated. The primary assessment was performed at the baseline visit and approximately 2 months after the start of treatment. The analysis was descriptive. Results. The series included 8 patients, 6 of whom were women; the mean age was 54.2±9.0 years. All patients had recurrent CRSwNP and a history of surgical interventions. Bronchial asthma was described in 5 of 8 patients, and intolerance to nonsteroidal anti-inflammatory drugs or Samster’s triad — in 4 of 8. Initially, the average score for VAS was 30.2±1.7, for SNOT-22 — 63.8±3.9. After 2 months, the mean VAS score decreased to 11.0±1.2, the average absolute change amounted to 19.2±1.5 points. The mean SNOT-22 score decreased to 30.1±5.8, with an average absolute change of –33.6±5.9 points. Improvement in VAS and SNOT-22 scores was observed in all 8 patients. The course of treatment was continued for all patients due to clinical improvement. Conclusion. In this small case series, tezepelumab was associated with an early reduction in symptom burden and improved quality of life in patients with severe recurrent rhinosinusitis with nasal polyps. The obtained observation results are preliminary. Confirmation in larger, systematically assembled cohorts with longer follow-up and standardized assessment of endoscopic, radiographic symptoms and safety indicators is needed.

  • Long-term therapy with dupilumab in treatment of polypous rhinosinusitis: treatment results and possible adverse reactions

    by V. I. Egorov, E. Yu. Savushkina, M. E. Dyneva, O. M. Kurbacheva

    Recurrent polypous rhinosinusitis, resistant to standard therapy, is a health problem worldwide. Recently, genetically engineered immunological drugs (GEIDs) have been used to treat recurrent polypous rhinosinusitis, which has helped to achieve disease control, avoid repeated surgical interventions on the paranasal sinuses, thereby reducing the workload of the surgical hospital. In addition, this led to an improvement in the patient’s quality of life: improved nasal breathing, olfaction, and emotional state. GEID therapy is long-term and continuous, since there is a risk of rapid relapse of the disease when treatment is discontinued. Given the specifics of the treatment, dynamic monitoring of the patient’s condition is necessary, since there is a risk of developing unwanted side effects, both previously known and individual. The integration of new treatment methods with a personalized approach and interdisciplinary control is a key factor in improving the quality of medical care for severe forms of polypous rhinosinusitis.

  • «Role and place of tezepelumab in the treatment of rhinosinusitis with nasal polyps». Resolution of the Expert Council

    by I.A. Kim, V.M. Svistushkin, E.V. Nosulya, A.V. Emelyanov, V.I. Egorov, S.V. Ryazantsev, S.A. Karpischenko, T.G. Pelishenko, F.M. Khanova

    The article presents a resolution of the Council of Experts: «Role and place of tezepelumab in the treatment of rhinosinusitis with nasal polyps», accepted following the discussion of the results of the WAYPOINT study, the expert consensus of EPOS/EUFOREA.

  • The optimization of patient management after otosurgical interventions

    by V.I. Egorov, A.O. Kochneva

    The auditory tube performs drainage, ventilation and protective functions. The impairments of those functions play an important role in the development of chronic middle ear pathology, in addition, they also largely determine the outcome of the disease and the results of surgical treatment. Protective and drainage functions are performed using the ciliated epithelium lining the lumen of the auditory tube. The results of our study showed that patients with chronic tubotimpanal otitis media, even with satisfactory patency of the auditory tube, may show signs of impaired drainage function, which may affect the success of tympanoplasty. Therefore, the appointment of mucoactive preparations, including the drug Sinupret, as a preoperative preparation, in order to improve mucociliary clearance, is appropriate and justified.

  • A clinical case of upper airway obstruction, dysphagia caused by diffuse idiopathic skeletal hyperostosis

    by V.I. Egorov, A.O. Kochneva, M.V. Gerasimenko

    Diffuse idiopathic skeletal hyperostosis (DISH, Forestier’s disease) is a rare non-inflammatory degenerative-dystrophic disease of the musculoskeletal system, characterized by calcification of ligaments and tendons, in particular the anterior longitudinal ligament. It is rare, more often among men over 60 years old. When the cervical spine is affected, DISH manifests itself as neck pain, stiffness of movement, dysphagia and, in some cases, difficulty breathing. The main goal of surgical treatment of Forestier’s disease is the removal of the osteophyte complex, however, with severe compression of the neck structures, indications may be given for the formation of a tracheostomy, installation of a nasogastric tube.

  • Monitoring microbiological effectiveness of no therapy in comprehensive treatment of neck phlegmon

    by V. I. Egorov, V. E. Arevina, E. V. Rusanova, D. M. Mustafaev, V. V. Shchelkova

    Аbstract. Insufficient attention to wound care in the postoperative period can lead to a protracted inflammatory process (wound chronicity) and the need for repeat surgeries. Furthermore, secondary infection in the hospital, lack of bacteriological monitoring of wound discharge, and ineffective selection of antibacterial therapy can significantly prolong the patient’s hospital stay. Proper surgical tactics and effective postoperative treatment measures contribute to improved treatment outcomes for patients with cervical phlegmon. Objective. To evaluate the microbiological effectiveness of NO (Nitric Oxide) therapy in the complex treatment of neck phlegmon. Patients and methods. The study included 40 people: 21 (52.5%) men and 19 (47.5%) women aged 18 to 62 years (28.5 [20.75; 37.25]) with a verified diagnosis of neck phlegmon. All patients underwent adequate surgical treatment. In the postoperative period, 20 patients of group 1 received daily NO therapy with the Plazon device according to the author’s method. 20 patients in group 2 received traditional treatment: systemic antibacterial therapy and local wound irrigation through drainage with an aqueous antiseptic solution and application of a bandage with antibacterial ointment. The treatment effectiveness was assessed by analyzing routine inflammation indices the microbial landscape of wound discharge upon admission and throughout treatment (on the 3rd, 5th and 7th days). Results. In group 1 (NO therapy), already on the 2nd day of the postoperative period, the total number of leukocytes decreased by 25.5% (p < 0.05); neutrophils, by 27% (p < 0.05); the LII value decreased by 9.4%; and ESR, by 1.6 times (p < 0.05). The CRP level decreased almost 2 times (p < 0.05). By the 6th day of observation, all indices were within normal values. The median number of the hospital stays in group 1 was 9.0 [8.0; 9.25]; in group 2, 11.0 [10.75; 13.0] — that is, 22.2% more (p < 0.05). In 77% of cases, the primary pathogen for neck phlegmon is S. aureus, with a concentration of 104–105 CFU/mL. S.viridans and E.faecalis are twice as common, isolated at concentrations of 104–105 CFU/mL. Monitoring of microbiological efficacy showed an increase from 60% on day 3 to 100% by day 7, which is a convincing indicator of the effectiveness of NO therapy in the treatment of neck phlegmon. Conclusion. The use of NO therapy allows restoring impaired homeostasis indices in a short time and stimulating tissue regeneration, it also helps reduce the length of hospital stay for patients.

  • Search for optimal and effective postoperative treatment for neck phlegmon

    by V. I. Egorov, D. M. Mustafaev, V. E. Arevina

    Аbstract. Today, postoperative treatment of patients with phlegmon of the neck remains one of the main and urgent problems in the practice of otolaryngologists and maxillofacial surgeons in the context of the worldwide growth of antibiotic resistance of microorganisms and the growth of morbidity with this pathology. In surgical departments dealing with the treatment of purulent-inflammatory processes, patients with purulent-inflammatory diseases of the face and neck occupy up to 50% of the beds. The number of new cases remains high and tends to increase. Inadequate wound management in the postoperative period can lead to the progression of the inflammatory process and the need for repeated operations, secondary nosocomial infection, lack of bacteriological control over wound discharge, inadequate antibacterial therapy. It also prolongs the terms of inpatient treatment. In recent years, more and more attention has been paid in clinical practice to nondrug methods of treating patients with inflammatory diseases, a special place among which is occupied by methods of physical influence. However, the use of physical factors, even such modern ones as high- and low-energy lasers, magnetic laser therapy, ultrasound, ozone therapy, etc. for the treatment of patients, does not always significantly affect the achievement of the desired result. Many aspects associated with postoperative management of purulent wounds still require attention and the search for new solutions. Experimental studies have shown that NO (nitric oxide) generated by a plasma-chemical method from atmospheric air normalizes microcirculation, accelerates the growth of granulation tissue and epithelialization. Gas supply through drains allows affecting all the walls of the purulent cavity providing an antibacterial effect, promotes the removal of pathological fluids, and accelerates wound healing.

  • Case report of transnasal removal of dacryolith blocking Hasner’s valve

    by E. V. Isaev, V. I. Egorov, V. N. Krasnozhen, Kazan Kazan State Medical Academy — a Branch «Russian Medical Academy Of Continuing Professional Education», O. M. Pustovit, N. K. Pereboev

    Relevance. Dacryolithiasis is a common disease of the lacrimal drainage system of the eye, which usually affects middle-aged women, is caused by the formation of stones (dacryoliths) in the lacrimal sac and nasolacrimal canal, and is often found during dacryocystorhinostomy. The origin of lacrimal stones is controversial. Traditionally, the development of stones in canaliculitis is associated with infection with Actinomyces spp. or the closely related genus Nocardia spp. Some evidence suggests that the entry of a foreign body into the lacrimal ducts can be a factor contributing to the formation of stones. Since dacryoliths are often an accidental finding during endoscopic endonasal dacryocystorhinostomy, this method of treatment is the main one for such pathology. Clinical case. Patient B., 19 years old, was admitted with complaints of constant lacrimation from the left eye, swelling in the area of the inner corner of the left eye, periodic purulent discharge from the left eye; these complaints had persisted for 6 months. According to CT of the lacrimal ducts with contrast, the patient was found to have obstruction of the left nasolacrimal duct at the level of the Hasner’s valve. A videoendoscopic endonasal revision of the lower nasal passage was performed, during which a foreign body (dacryolith) was found obstructing the area of the Hasner’s valve. The foreign body was removed instrumentally, and the patency of the lacrimal ducts was completely restored. Conclusion. A 19-year-old patient underwent successful surgical treatment of chronic left-sided dacryocystitis by revision of the Hasner’s valve and elimination of its obstruction by removing a foreign body.

  • Case report of transnasal endoscopic removal of large nasal hemangioma

    by E. V. Isaev, V. I. Egorov, D. M. Mustafaev, N. K. Pereboev

    Background. Hemangiomas are common benign tumors arising from blood vessels, resulting from the proliferation of endothelial cells surrounding blood-filled cavities; they are closer in nature to developmental defects. Despite the fact that hemangioma is the most common soft tissue formation of the head and neck, they are rarely found in the nasal cavity and paranasal sinuses. During its growth, nasal hemangioma obstructs the nasal cavity and, ultimately, compresses the surrounding structures. In the future, even destruction of bone tissue is possible and manifests itself, as a rule, in the form of recurrent nosebleeds with minor injuries, hemoptysis, runny nose, lacrimation from the eyes, and difficulty nasal breathing. Non-radical removal of a tumor-like formation leads to relapse. Therefore, the main treatment method for hemangiomas, especially deep ones, is surgical excision with preoperative embolization to reduce intraoperative bleeding. Modern capabilities of endoscopic technology allow for a minimally invasive transnasal approach to the formation and its removal with minimal blood loss. Clinical case. Female patient P., 57 years old, was admitted with complaints of periodic bleeding from the left half of the nose, lack of nasal breathing on the left, purulent discharge from the nasal cavity on the left, a feeling of mucus running down the back wall of the throat, periodic headaches. An MRI of the brain with contrast was performed revealing a mass formation in the left half of the nasal cavity, measuring 4 × 3 × 1.5 cm, taking into account the signal characteristics, a hemangioma is more likely. In order to prevent bleeding, before removing the vascular formation, CT angiography was performed followed by selective embolization of the distal parts of the left maxillary artery supplying the hemangioma. The vascular anomaly was removed by surgical transnasal endoscopic method. Conclusion. A 57-year-old patient underwent successful surgical treatment of hemangioma of the nasal cavity and paranasal sinuses with preliminary embolization of the afferent vessels using radical transnasal endoscopic excision of the arteriovenous malformation. There were no complications in the postoperative period.